McKesson Corporation (MCK), a healthcare company, said on Tuesday that it has revised up its annual adjusted earnings outlook, better than analysts' projections.
The company now expects full-year adjusted income per share of $38.05 to $38.55, compared with the earlier guidance of $37.10 to $37.90 per share.
On average, 14 analysts polled forecast McKesson to earn $37.48 per share for the full year. Analysts' expectations typically exclude special items.
In addition, McKesson has revised up its long-term adjusted earnings per share growth target to a range of 13% to 16%, compared with the prior range of 12% to 14%. "This reflects the strength of McKesson's leading platforms in oncology, multispecialty, and biopharma solutions, supported by operating leverage and efficient capital deployment," the company said.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.